Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
VistaGen Therapeutics, Inc. (VTGN)
USD0.25
+0.00 (+1.14%)
US NASDAQ Healthcare Biotechnology
Address
343 Allerton Avenue 94080
South San Francisco, CA, US
South San Francisco, CA, US
CEO
Shawn K. Singh
Website
vistagen.com
IPO
2011-06-21
CIK 1411685 ISIN US92840H4002
Description
VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical entity dedicated to advancing and commercializing innovative medications for anxiety, depression, and various other disorders impacting the central nervous system (CNS). A key component of its CNS pipeline is PH94B, a fast-acting neuroactive nasal spray currently in Phase III trials for the rapid treatment of anxiety in adults experiencing social anxiety disorder. PH94B also shows potential for addressing a broader spectrum of anxiety conditions, including adjustment disorder with anxiety, postpartum anxiety, post-traumatic stress disorder (PTSD), pre-procedural anxiety, and panic disorders. The company's CNS development initiatives further encompass PH10, another quick-acting neuroactive nasal spray, which is in preparation for Phase 2B clinical assessment as a standalone therapy for major depressive disorder (MDD). Additionally, VistaGen is developing AV-101, an oral N-methyl-D-aspartate receptor antagonist, which is being investigated in conjunction with oral probenecid for its potential application in treating levodopa-induced dyskinesia, MDD, neuropathic pain, and suicidal ideation. VistaGen has established various collaborations, including a contract research and development agreement with Cato Research Ltd., a licensing agreement with Pherin Pharmaceuticals, Inc., and a license and collaboration agreement with EverInsight Therapeutics Inc. Founded in 1998, VistaGen Therapeutics, Inc. is headquartered in South San Francisco, California.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.25
+0.00 (+1.14%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
958.6K
Beta
0.29
Float Shares
29.19M
Free Float %
89.1%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.56% | +6.11% | -8.31% | -5.65% | -86.95% | -13.43% | -75.72% | -72.45% | -99.31% | -99.51% | -99.96% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (7 ratings, all time)
Hold
Price Targets & DCF
Current price
0.25
Low
0.90
+261.6%
Consensus
0.95
+281.7%
Median
0.95
+281.7%
High
1.00
+301.8%
DCF (Unlevered)
2.11
+747.6%
DCF (Levered)
2.13
+755.1%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
0% Bullish
| Rating | 2026-06 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | -1 |
| Hold | 5 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 3 |
4.63
+1,760.2%
|
| All Time | 4 |
4.97
+1,896.8%
|
Quality scores
Altman Z-Score
-16.76
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
2 / 10
No MOAT
Composite Rating
B
Overall Score
3 / 5
Medium
DCF Score
5 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+161.1% ★ Q1'26: +3,193.3% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%-9.6% Q1'26: +15.9% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-5,684.2% Q1'26: -3,518.3% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%+0.0% Q1'26: +0.0% (vs Q1'25)
-
ROIC Biotechnology: -16.1%— Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+24.0% Q1'26: +24.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.01× Q1'26: -0.02× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Mar 2017 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 3 Rev. Ana. 3 EPS Ana. |
Mar 2027 3 Rev. Ana. 3 EPS Ana. |
Mar 2028 2 Rev. Ana. 2 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.25M
est: 1.00M (+25.0%)
|
1.09M
est: 877.3K (+24.2%)
|
1.11M
est: 1.32M (-16.3%)
|
-227.0K
est: -403.0K (+43.7%)
|
1.06M
est: 971.0K (+9.6%)
|
486.0K
est: 709.8K (-31.5%)
|
1.03M
779.9K – 1.28M
+45.6% YoY
|
500.0K
500.0K – 500.0K
-51.6% YoY
|
7.00M
7.00M – 7.00M
+1,300.0% YoY
|
20.00M
20.00M – 20.00M
+185.7% YoY
|
80.00M
80.00M – 80.00M
+300.0% YoY
|
| EBITDA |
-9.77M
est: -600.0K (-1,527.8%)
|
-17.44M
est: -526.4K (-3,213.4%)
|
-47.05M
est: -794.7K (-5,820.3%)
|
-58.74M
est: 241.8K (-24,391.1%)
|
-28.79M
est: -582.6K (-4,841.6%)
|
-50.78M
est: -425.9K (-11,822.1%)
|
-620.0K
-766.2K – -467.9K
-45.6% YoY
|
-300.0K
-300.0K – -300.0K
+51.6% YoY
|
-4.20M
-4.20M – -4.20M
-1,300.0% YoY
|
-12.00M
-12.00M – -12.00M
-185.7% YoY
|
-48.00M
-48.00M – -48.00M
-300.0% YoY
|
| EBIT |
-9.82M
est: -600.0K (-1,537.0%)
|
-17.92M
est: -526.4K (-3,304.1%)
|
-47.76M
est: -794.7K (-5,909.8%)
|
-59.27M
est: 241.8K (-24,611.2%)
|
-29.36M
est: -582.6K (-4,939.1%)
|
-51.41M
est: -425.9K (-11,971.2%)
|
-620.0K
-766.2K – -467.9K
-45.6% YoY
|
-300.0K
-300.0K – -300.0K
+51.6% YoY
|
-4.20M
-4.20M – -4.20M
-1,300.0% YoY
|
-12.00M
-12.00M – -12.00M
-185.7% YoY
|
-48.00M
-48.00M – -48.00M
-300.0% YoY
|
| Net Income |
-10.26M
est: -1.75B (+99.4%)
|
-17.93M
est: -195.79M (+90.8%)
|
-47.76M
est: -205.00M (+76.7%)
|
-59.25M
est: -260.13M (+77.2%)
|
-29.36M
est: -40.50M (+27.5%)
|
-51.42M
est: -53.19M (+3.3%)
|
-54.52M
-56.12M – -52.92M
-2.5% YoY
|
-33.55M
-36.51M – -30.60M
+38.5% YoY
|
-54.69M
-65.06M – -28.92M
-63.0% YoY
|
-22.73M
-22.73M – -22.73M
+58.4% YoY
|
-17.20M
-17.20M – -17.20M
+24.3% YoY
|
| SGA |
5.87M
est: 446.4K (+1,214.4%)
|
7.10M
est: 391.7K (+1,712.3%)
|
13.25M
est: 591.3K (+2,140.6%)
|
14.66M
est: -179.9K (+8,250.7%)
|
14.06M
est: 433.5K (+3,144.2%)
|
17.08M
est: 316.9K (+5,291.2%)
|
461.3K
348.2K – 570.1K
+45.6% YoY
|
223.2K
223.2K – 223.2K
-51.6% YoY
|
3.12M
3.12M – 3.12M
+1,300.0% YoY
|
8.93M
8.93M – 8.93M
+185.7% YoY
|
35.71M
35.71M – 35.71M
+300.0% YoY
|
| EPS |
-40.85
est: -57.00 (+28.3%)
|
-14.74
est: -6.38 (-131.2%)
|
-7.38
est: -6.68 (-10.6%)
|
-8.51
est: -8.40 (-1.3%)
|
-1.52
est: -1.32 (-15.3%)
|
-1.67
est: -1.74 (+3.8%)
|
-1.78
-1.83 – -1.72
-2.5% YoY
|
-1.10
-1.19 – -1.00
+38.4% YoY
|
-1.53
-2.12 – -0.94
-39.5% YoY
|
-0.74
-0.74 – -0.74
+51.6% YoY
|
-0.56
-0.56 – -0.56
+24.3% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-15 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-06-12 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-06-11 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-06-10 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-06-09 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-06-08 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-06-05 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-06-04 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-06-03 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-06-02 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-06-01 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-28 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-27 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-26 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-22 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-21 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-20 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-19 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-18 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-15 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-14 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-13 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-12 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-11 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-08 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-07 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-06 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-05 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-04 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-01 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-30 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-29 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-28 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-27 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-24 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-23 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-22 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-21 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-20 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-17 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-16 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-59.93M
OE per share TTM
-1.71
Owner's Yield
-274.69%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
500.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
61
Total invested
8.12M
Insider transactions (90d)
1
Beneficial owners (>5%)
36
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Venrock Healthcare Capital Partners II, L.P. | 20.70M | 10.00% | — | 206.97M | — | 206.97M | PN | Delaware | 2022-07-08 | ↗ |
| 2 | Koh, Bong | 16.05M | 8.00% | — | 16.05M | — | — | IN | United States | 2022-02-14 | ↗ |
| 3 | Shah, Nimish | 16.05M | 8.00% | — | 16.05M | — | — | IN | United States | 2022-02-14 | ↗ |
| 4 | VHCP Co-Investment Holdings II, LLC | 16.05M | 8.00% | — | 16.05M | — | — | OO | Delaware | 2022-02-14 | ↗ |
| 5 | VHCP Management EG, LLC | 16.05M | 8.00% | — | 16.05M | — | — | OO | Delaware | 2022-02-14 | ↗ |
| 6 | VHCP Management II, LLC | 16.05M | 8.00% | — | 16.05M | — | — | OO | Delaware | 2022-02-14 | ↗ |
| 7 | Venrock Healthcare Capital Partners EG, L.P. | 16.05M | 8.00% | — | 16.05M | — | — | PN | Delaware | 2022-02-14 | ↗ |
| 8 | Management II, LLC | 14.24M | 9.99% | — | 14.24M | — | — | OO | Delaware | 2021-02-16 | ↗ |
| 9 | Acuta Capital Partners, LLC | 12.46M | 8.40% | — | 12.46M | — | 12.46M | IA, OO | Delaware | 2021-03-22 | ↗ |
| 10 | Anupam Dalal | 12.46M | 8.40% | — | 12.46M | — | 12.46M | HC, IN | United States | 2021-03-22 | ↗ |
| 11 | (1) BlackRock, Inc. | 11.89M | 6.00% | 11.82M | — | 11.89M | — | HC | Delaware | 2022-02-04 | ↗ |
| 12 | OrbiMed Capital LLC | 10.52M | 5.30% | 10.52M | — | 10.52M | — | OO | Delaware | 2022-02-11 | ↗ |
| 13 | Commodore Capital LP | 10.46M | 5.10% | — | 10.46M | — | — | IA | Delaware, USA | 2022-04-14 | ↗ |
| 14 | Commodore Capital Master LP | 10.46M | 5.10% | — | 10.46M | — | — | OO | Delaware, USA | 2022-04-14 | ↗ |
| 15 | Franklin Resources, Inc. | 10.12M | 5.10% | 4.00 | 4.00 | 4.00 | 4.00 | HC | Delaware | 2022-02-04 | ↗ |
| 16 | Acuta Capital Fund, LP | 9.66M | 6.50% | — | 9.66M | — | 9.66M | PN | Delaware | 2021-03-22 | ↗ |
| 17 | Daniel Mack | 2.80M | 9.90% | — | 2.80M | — | — | HC | USA | 2024-02-14 | ↗ |
| 18 | Nantahala Capital Management, LLC | 2.80M | 9.90% | — | 2.80M | — | — | IA | MA | 2024-02-14 | ↗ |
| 19 | Wilmot B. Harkey | 2.80M | 9.90% | — | 2.80M | — | — | HC | USA | 2024-02-14 | ↗ |
| 20 | Dr. Jeffrey R. Jay, M.D. | 2.79M | 9.99% | — | 2.79M | — | — | HC, IN | USA | 2023-10-12 | ↗ |
| 21 | Great Point Partners, LLC | 2.79M | 9.99% | — | 2.79M | — | — | IA, OO | Delaware | 2023-10-12 | ↗ |
| 22 | Mr. Ortav Yehudai | 2.79M | 9.99% | — | 2.79M | — | — | HC, IN | USA | 2023-10-12 | ↗ |
| 23 | BVF Partners L.P. | 2.78M | 9.99% | — | 143.4K | — | 143.4K | IA, PN | Cayman Islands | 2023-10-16 | ↗ |
| 24 | Chen Yu | 2.70M | 9.90% | — | 2.70M | — | 2.70M | IN | Delaware | 2023-10-16 | ↗ |
| 25 | OrbiMed Advisors LLC | 2.39M | 1.20% | — | 2.39M | — | — | IA | Delaware | 2022-02-11 | ↗ |
| 26 | Capital LP | 2.37M | 9.90% | — | 2.37M | — | 2.37M | IA | USA | 2023-10-06 | ↗ |
| 27 | Capital Master LP | 2.37M | 9.90% | — | 2.37M | — | 2.37M | OO | Islands | 2023-10-06 | ↗ |
| 28 | TCG Crossover Fund II, L.P. | 2.03M | 7.50% | — | 2.03M | — | 2.03M | PN | Delaware | 2023-10-16 | ↗ |
| 29 | TCG Crossover GP II, LLC | 2.03M | 7.50% | — | 2.03M | — | 2.03M | OO | Delaware | 2023-10-16 | ↗ |
| 30 | The Vanguard Group - 23-1945930 | 1.83M | 6.79% | — | — | 1.82M | 10.8K | IA | Pennsylvania | 2024-02-13 | ↗ |
| 31 | Point72 Asset Management, L.P. | 1.57M | 5.60% | — | 1.57M | — | — | PN | Delaware | 2023-10-05 | ↗ |
| 32 | Point72 Capital Advisors, Inc. | 1.57M | 5.60% | — | 1.57M | — | — | CO | Delaware | 2023-10-05 | ↗ |
| 33 | Steven A. Cohen | 1.57M | 5.60% | — | 1.57M | — | — | IN | United States | 2023-10-05 | ↗ |
| 34 | TCG Crossover Fund I, L.P. | 669.1K | 2.50% | — | 669.1K | — | 669.1K | PN | Delaware | 2023-10-16 | ↗ |
| 35 | TCG Crossover GP I, LLC | 669.1K | 2.50% | — | 669.1K | — | 669.1K | OO | Delaware | 2023-10-16 | ↗ |
| 36 | 2. | 10.00 | 0.10% | — | 28.1K | — | — | BD, OO | Delaware | 2023-10-16 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
61
-3 vs prev Q
New positions
16
Closed positions
15
Increased
31
Reduced
10
Put/Call ratio
0.07
Calls held
516.8K
Puts held
35.7K
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | TCG CROSSOVER MANAGEMENT, LLC | 2.68M +— (+0.0%) | 1.77M -7.7M (-81.4%) | 6.34% -2.045 pp | 0.06% -0.409 pp | USD3.01 -78.1% | 6 qtrs — |
| 2 | VANGUARD GROUP INC | 1.82M +137.0K (+8.1%) | 1.21M -4.8M (-79.8%) | 4.32% -0.965 pp | 0.00% 0.000 pp | USD4.25 -84.5% | 11 qtrs — |
| 3 | IKARIAN CAPITAL, LLC | 519.1K -101.8K (-16.4%) | 343.6K -1.9M (-84.4%) | 1.23% -0.715 pp | 0.03% -0.196 pp | USD2.59 -74.5% | 5 qtrs — |
| 4 | CITADEL ADVISORS LLC | 465.1K +365.6K (+367.4%) | 307.9K -45.4K (-12.8%) | 1.10% +0.790 pp | 0.00% +0.000 pp | USD1.17 -43.6% | 10 qtrs — |
| 5 | BLACKROCK, INC. | 422.8K -369.0 (-0.1%) | 279.8K -1.2M (-81.4%) | 1.00% -0.324 pp | 0.00% +0.000 pp | USD3.01 -78.1% | 6 qtrs — |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 352.8K +54.6K (+18.3%) | 233.6K -825.7K (-77.9%) | 0.84% -0.099 pp | 0.00% 0.000 pp | USD3.70 -82.2% | 11 qtrs — |
| 7 | LUMINUS MANAGEMENT LLC | 350.0K +350.0K (+100.0%) | 231.7K +231.7K (+100.0%) | 0.83% +0.829 pp | 0.20% +0.203 pp | USD0.66 +0.0% | 1 qtrs NEW |
| 8 | ADVISORSHARES INVESTMENTS LLC | 250.2K +43.2K (+20.9%) | 165.6K -569.2K (-77.5%) | 0.70% +0.052 pp | 0.03% -0.092 pp | USD2.76 -76.1% | 9 qtrs — |
| 9 | STEMPOINT CAPITAL LP | 616.7K -1.9M (-75.2%) | 142.1K -7.6M (-98.2%) | 1.46% -6.334 pp | 0.02% -1.528 pp | USD4.57 -85.6% | 9 qtrs — |
| 10 | MILLENNIUM MANAGEMENT LLC | 197.0K +176.4K (+853.0%) | 130.4K +57.0K (+77.7%) | 0.47% +0.402 pp | 0.00% +0.000 pp | USD0.96 -31.3% | 2 qtrs — |
| 11 | TWO SIGMA INVESTMENTS, LP | 195.6K -93.8K (-32.4%) | 129.4K -898.0K (-87.4%) | 0.46% -0.443 pp | 0.00% -0.001 pp | USD3.67 -82.0% | 9 qtrs — |
| 12 | RENAISSANCE TECHNOLOGIES LLC | 160.8K -261.2K (-61.9%) | 106.4K -1.4M (-92.9%) | 0.38% -0.941 pp | 0.00% -0.002 pp | USD3.51 -81.2% | 8 qtrs — |
| 13 | DIMENSIONAL FUND ADVISORS LP | 151.9K +83.9K (+123.3%) | 100.6K -140.8K (-58.3%) | 0.42% +0.212 pp | 0.00% +0.000 pp | USD1.57 -58.0% | 4 qtrs — |
| 14 | TWO SIGMA ADVISERS, LP | 137.7K -19.3K (-12.3%) | 91.2K -466.3K (-83.6%) | 0.33% -0.166 pp | 0.00% -0.001 pp | USD3.36 -80.4% | 5 qtrs — |
| 15 | BOOTHBAY FUND MANAGEMENT, LLC | 134.6K -62.5K (-31.7%) | 89.1K -610.4K (-87.3%) | 0.32% -0.298 pp | 0.00% -0.009 pp | USD2.65 -75.1% | 5 qtrs — |
| 16 | STATE STREET CORP | 121.1K +24.3K (+25.0%) | 80.2K -263.7K (-76.7%) | 0.29% -0.017 pp | 0.00% +0.000 pp | USD3.42 -80.7% | 11 qtrs — |
| 17 | ADAR1 CAPITAL MANAGEMENT, LLC | 120.0K +120.0K (+100.0%) | 79.4K +79.4K (+100.0%) | 0.28% +0.284 pp | 0.01% +0.006 pp | USD0.66 +0.0% | 1 qtrs NEW |
| 18 | DIADEMA PARTNERS LP | 106.5K +6.3K (+6.3%) | 70.5K -285.2K (-80.2%) | 0.25% -0.062 pp | 0.01% -0.079 pp | USD3.38 -80.5% | 5 qtrs — |
| 19 | GROUP ONE TRADING, L.P. | 106.1K +77.2K (+266.9%) | 70.3K -32.4K (-31.6%) | 0.25% +0.161 pp | 0.00% 0.000 pp | USD1.39 -52.5% | 5 qtrs — |
| 20 | OMERS ADMINISTRATION CORP | 103.4K +103.4K (+100.0%) | 68.4K +68.4K (+100.0%) | 0.24% +0.245 pp | 0.00% +0.001 pp | USD0.66 +0.0% | 1 qtrs NEW |
| 21 | JANE STREET GROUP, LLC | 79.7K +79.7K (+100.0%) | 52.8K +52.8K (+100.0%) | 0.19% +0.189 pp | 0.00% +0.000 pp | USD0.66 +0.0% | 1 qtrs NEW |
| 22 | TUDOR INVESTMENT CORP ET AL | 76.2K +76.2K (+100.0%) | 50.4K +50.4K (+100.0%) | 0.18% +0.180 pp | 0.00% +0.000 pp | USD0.66 +0.0% | 1 qtrs NEW |
| 23 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 75.0K +60.5K (+417.2%) | 49.5K -2.0K (-3.8%) | 0.18% +0.132 pp | 0.00% +0.000 pp | USD1.22 -45.9% | 2 qtrs — |
| 24 | NORTHERN TRUST CORP | 72.7K +24.6K (+51.1%) | 48.1K -122.6K (-71.8%) | 0.17% +0.021 pp | 0.00% +0.000 pp | USD3.11 -78.8% | 11 qtrs — |
| 25 | — | 62.7K +62.7K (+100.0%) | 41.5K +41.5K (+100.0%) | 0.15% +0.149 pp | 0.03% +0.032 pp | USD0.66 +0.0% | 1 qtrs NEW |
| 26 | CAPTION MANAGEMENT, LLC | 61.4K +61.4K (+100.0%) | 40.6K +40.6K (+100.0%) | 0.15% +0.145 pp | 0.00% +0.000 pp | USD0.66 +0.0% | 1 qtrs NEW |
| 27 | QUBE RESEARCH & TECHNOLOGIES LTD | 60.1K +60.1K (+100.0%) | 39.8K +39.8K (+100.0%) | 0.14% +0.142 pp | 0.00% +0.000 pp | USD0.66 +0.0% | 1 qtrs NEW |
| 28 | OCCUDO QUANTITATIVE STRATEGIES LP | 59.0K +16.3K (+38.2%) | 39.1K -112.5K (-74.2%) | 0.14% +0.006 pp | 0.00% -0.016 pp | USD2.75 -76.0% | 2 qtrs — |
| 29 | UBS GROUP AG | 52.0K +26.3K (+102.6%) | 34.4K -56.7K (-62.2%) | 0.12% +0.043 pp | 0.00% +0.000 pp | USD1.86 -64.5% | 11 qtrs — |
| 30 | AMERICAN CENTURY COMPANIES INC | 48.8K +7.7K (+18.7%) | 32.3K -113.5K (-77.9%) | 0.12% -0.013 pp | 0.00% 0.000 pp | USD3.84 -82.8% | 8 qtrs — |
| 31 | ORBIMED ADVISORS LLC | 45.2K +— (+0.0%) | 29.9K -130.5K (-81.4%) | 0.11% -0.035 pp | 0.00% -0.003 pp | USD3.55 -81.4% | 2 qtrs — |
| 32 | VIRTU FINANCIAL LLC | 37.7K +37.7K (+100.0%) | 25.0K +25.0K (+100.0%) | 0.09% +0.089 pp | 0.00% +0.001 pp | USD0.66 +0.0% | 3 qtrs — |
| 33 | HRT FINANCIAL LP | 37.6K +37.6K (+100.0%) | 24.0K +24.0K (+100.0%) | 0.09% +0.089 pp | 0.00% +0.000 pp | USD0.66 +0.0% | 1 qtrs NEW |
| 34 | ENGINEERS GATE MANAGER LP | 30.5K +30.5K (+100.0%) | 20.2K +20.2K (+100.0%) | 0.07% +0.072 pp | 0.00% +0.000 pp | USD0.66 +0.0% | 1 qtrs NEW |
| 35 | PERSISTENT ASSET PARTNERS LTD | 26.6K -48.7K (-64.7%) | 17.6K -249.8K (-93.4%) | 0.06% -0.173 pp | 0.01% -0.176 pp | USD2.95 -77.6% | 5 qtrs — |
| 36 | KESTRA ADVISORY SERVICES, LLC | 26.0K +6.0K (+30.0%) | 17.2K -53.9K (-75.8%) | 0.06% -0.001 pp | 0.00% 0.000 pp | USD2.47 -73.3% | 6 qtrs — |
| 37 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 23.3K +— (+0.0%) | 15.4K -67.3K (-81.4%) | 0.07% -0.008 pp | 0.00% +0.000 pp | USD5.14 -87.2% | 9 qtrs — |
| 38 | SCHONFELD STRATEGIC ADVISORS LLC | 21.7K +10.9K (+99.7%) | 14.4K -24.2K (-62.8%) | 0.05% +0.017 pp | 0.00% 0.000 pp | USD2.11 -68.7% | 2 qtrs — |
| 39 | HIGHTOWER ADVISORS, LLC | 20.6K -200.0 (-1.0%) | 13.7K -60.3K (-81.5%) | 0.06% -0.008 pp | 0.00% 0.000 pp | USD3.01 -78.1% | 6 qtrs — |
| 40 | LIGHTHOUSE INVESTMENT PARTNERS, LLC | 20.6K +20.6K (+100.0%) | 13.6K +13.6K (+100.0%) | 0.05% +0.049 pp | 0.00% +0.000 pp | USD0.66 +0.0% | 1 qtrs NEW |
| 41 | SHAY CAPITAL LLC | 20.2K +20.2K (+100.0%) | 13.4K +13.4K (+100.0%) | 0.05% +0.048 pp | 0.00% +0.001 pp | USD0.66 +0.0% | 1 qtrs NEW |
| 42 | MARSHALL WACE, LLP | 20.0K +20.0K (+100.0%) | 13.2K +13.2K (+100.0%) | 0.05% +0.047 pp | 0.00% +0.000 pp | USD0.66 +0.0% | 3 qtrs — |
| 43 | TRUVESTMENTS CAPITAL LLC | 17.0K +8.3K (+96.3%) | 11.2K -19.5K (-63.4%) | 0.04% +0.013 pp | 0.00% -0.004 pp | USD1.48 -55.4% | 3 qtrs — |
| 44 | STONEX GROUP INC. | 13.3K +13.3K (+100.0%) | 8.8K +8.8K (+100.0%) | 0.04% +0.037 pp | 0.00% +0.000 pp | USD0.66 +0.0% | 1 qtrs NEW |
| 45 | MORGAN STANLEY | 12.7K -14.9K (-54.0%) | 8.4K -89.4K (-91.4%) | 0.03% -0.056 pp | 0.00% +0.000 pp | USD3.24 -79.6% | 11 qtrs — |
| 46 | DRW SECURITIES, LLC | 10.0K +10.0K (+100.0%) | 6.6K +6.6K (+100.0%) | 0.02% +0.024 pp | 0.00% +0.000 pp | USD0.66 +0.0% | 1 qtrs NEW |
| 47 | TOWER RESEARCH CAPITAL LLC (TRC) | 8.6K +8.6K (+100.0%) | 5.7K +5.7K (+100.0%) | 0.02% +0.020 pp | 0.00% +0.000 pp | USD0.66 +0.0% | 9 qtrs — |
| 48 | ADVISOR GROUP HOLDINGS, INC. | 5.3K +1.2K (+28.7%) | 3.5K -11.0K (-75.9%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD3.78 -82.5% | 11 qtrs — |
| 49 | BANK OF AMERICA CORP /DE/ | 3.1K -31.5K (-90.9%) | 2.1K -121.0K (-98.3%) | 0.01% -0.101 pp | 0.00% +0.000 pp | USD3.42 -80.7% | 11 qtrs — |
| 50 | PERFORMA LTD (US), LLC | 1.0K +— (+0.0%) | 662.00 -2.9K (-81.4%) | 0.00% 0.000 pp | 0.00% -0.001 pp | USD2.95 -77.6% | 5 qtrs — |
| 51 | MAI CAPITAL MANAGEMENT | 526.00 +— (+0.0%) | 349.00 -1.5K (-81.3%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD2.95 -77.6% | 5 qtrs — |
| 52 | SBI SECURITIES CO., LTD. | 288.00 -2.0 (-0.7%) | 191.00 -839.0 (-81.5%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD2.94 -77.6% | 5 qtrs — |
| 53 | JONES FINANCIAL COMPANIES LLLP | 114.00 +— (+0.0%) | 75.00 -327.0 (-81.3%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD3.11 -78.8% | 9 qtrs — |
| 54 | FAIRMAN GROUP, LLC | 29.00 +— (+0.0%) | 19.00 -84.0 (-81.6%) | 0.00% +0.000 pp | 0.00% 0.000 pp | USD5.14 -87.2% | 9 qtrs — |
| 55 | JPMORGAN CHASE & CO | 16.00 -271.8K (-100.0%) | 11.00 -965.0K (-100.0%) | 0.00% -0.851 pp | 0.00% 0.000 pp | USD2.94 -77.6% | 11 qtrs — |
| 56 | BNP PARIBAS ARBITRAGE, SNC | 13.00 -43.0 (-76.8%) | 9.00 -190.0 (-95.5%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD2.92 -77.4% | 5 qtrs — |
| 57 | GSA CAPITAL PARTNERS LLP | — -31.5K (-100.0%) | — -112.0K (-100.0%) | 0.00% -0.099 pp | 0.00% -0.009 pp | USD— | 2 qtrs SOLD |
| 58 | COMMODORE CAPITAL LP | — -1.6M (-100.0%) | — -5.6M (-100.0%) | 0.00% -4.933 pp | 0.00% -0.273 pp | USD— | 10 qtrs SOLD |
| 59 | CITIGROUP INC | — -3.5K (-100.0%) | — -12.3K (-100.0%) | 0.00% -0.011 pp | 0.00% +0.000 pp | USD— | 11 qtrs SOLD |
| 60 | JANUS HENDERSON GROUP PLC | — -4.2M (-100.0%) | — -14.7M (-100.0%) | 0.00% -13.046 pp | 0.00% -0.007 pp | USD— | 2 qtrs SOLD |
| 61 | BML CAPITAL MANAGEMENT, LLC | — -150.0K (-100.0%) | — -532.5K (-100.0%) | 0.00% -0.470 pp | 0.00% -0.488 pp | USD— | 10 qtrs SOLD |
| 62 | BLAIR WILLIAM & CO/IL | — -12.6K (-100.0%) | — -44.6K (-100.0%) | 0.00% -0.039 pp | 0.00% 0.000 pp | USD— | 10 qtrs SOLD |
| 63 | BARCLAYS PLC | — -1.0 (-100.0%) | — -4.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 4 qtrs SOLD |
| 64 | ALMITAS CAPITAL LLC | — -261.4K (-100.0%) | — -928.0K (-100.0%) | 0.00% -0.819 pp | 0.00% -0.212 pp | USD— | 5 qtrs SOLD |
| 65 | WALLEYE CAPITAL LLC | — -67.8K (-100.0%) | — -240.6K (-100.0%) | 0.00% -0.212 pp | 0.00% -0.001 pp | USD— | 2 qtrs SOLD |
| 66 | XTX TOPCO LTD | — -69.7K (-100.0%) | — -247.5K (-100.0%) | 0.00% -0.218 pp | 0.00% -0.013 pp | USD— | 2 qtrs SOLD |
| 67 | FNY INVESTMENT ADVISERS, LLC | — -6.0K (-100.0%) | — -21.0K (-100.0%) | 0.00% -0.019 pp | 0.00% -0.007 pp | USD— | 2 qtrs SOLD |
| 68 | NANTAHALA CAPITAL MANAGEMENT, LLC | — -2.0M (-100.0%) | — -7.0M (-100.0%) | 0.00% -6.196 pp | 0.00% -0.244 pp | USD— | 9 qtrs SOLD |
| 69 | GOLDMAN SACHS GROUP INC | — -60.2K (-100.0%) | — -213.5K (-100.0%) | 0.00% -0.188 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 70 | SOLEUS CAPITAL MANAGEMENT, L.P. | — -550.0K (-100.0%) | — -2.0M (-100.0%) | 0.00% -1.723 pp | 0.00% -0.098 pp | USD— | 2 qtrs SOLD |
| 71 | QUADRATURE CAPITAL LTD | — -15.8K (-100.0%) | — -55.8K (-100.0%) | 0.00% -0.049 pp | 0.00% -0.001 pp | USD— | 2 qtrs SOLD |
| 72 | CWM, LLC | — -582.0 (-100.0%) | — -2.0K (-100.0%) | 0.00% -0.002 pp | 0.00% +0.000 pp | USD— | 11 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 12 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | AdvisorShares Psychedelics ETF PSIL | 0.26% | 113.1K | 1.84% |
| 2 | Vanguard Extended Market ETF VXF | 0.00% | 254.8K | 0.05% |
| 3 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 1.5K | 0.03% |
| 4 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 4.3K | 0.17% |
| 5 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 314.19 | 0.17% |
| 6 | Vanguard Total Stock Market ETF VTI | 0.00% | 727.0K | 0.03% |
| 7 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 1.6K | 0.22% |
| 8 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 867.42 | 0.22% |
| 9 | Vanguard Balanced ETF Portfolio VBAL.TO | 0.00% | 350.35 | 0.22% |
| 10 | Vanguard Conservative ETF Portfolio VCNS.TO | 0.00% | 38.62 | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
9
Sells
0
Shares acquired
525.0K
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+525,000
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-18 | Angelov Angel S | Officer | A-Award | A | Stock Option (Right to Buy) | 150,000 | 0.60 | 89.3K | 150,000 | D | ↗ |
| 2026-04-07 | Tressler Nick B. | Officer | A-Award | A | Incentive Stock Option (right to buy) | 75,000 | 0.54 | 40.2K | 75,000 | D | ↗ |
| 2026-04-07 | Singh Shawn | Director / Officer | A-Award | A | Incentive Stock Option (right to buy) | 3,732 | 0.54 | 2.0K | 3,732 | D | ↗ |
| 2026-04-07 | Prince Joshua S. | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 56,248 | 0.54 | 30.1K | 56,248 | D | ↗ |
| 2026-04-07 | Cote Elissa S. | Officer | A-Award | A | Incentive Stock Option (right to buy) | 75,000 | 0.54 | 40.2K | 75,000 | D | ↗ |
| 2026-04-07 | Adler Reid G. | Officer | A-Award | A | Incentive Stock Option (right to buy) | 18,753 | 0.54 | 10.0K | 18,753 | D | ↗ |
| 2025-12-31 | Prince Joshua S. | Officer | A-Award | A | Common Stock | 4,386 | 0.56 | 2.5K | 15,249 | D | ↗ |
| 2025-12-01 | Tressler Nick B. | Officer | A-Award | A | Common Stock (Right to Buy) | 150,000 | 4.43 | 664.5K | 150,000 | D | ↗ |
| 2025-10-27 | Edick Paul R | Director | A-Award | A | Stock Option (Right to Buy) | 35,200 | 3.90 | 137.3K | 35,200 | D | ↗ |
| 2025-09-09 | SAXE JON S | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 17,600 | 3.61 | 63.5K | 17,600 | D | ↗ |
| 2025-09-09 | Rotunno Mary L. | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 17,600 | 3.61 | 63.5K | 17,600 | D | ↗ |
| 2025-09-09 | FitzPatrick Margaret M | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 17,600 | 3.61 | 63.5K | 17,600 | D | ↗ |
| 2025-09-09 | Curley Joanne | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 17,600 | 3.61 | 63.5K | 17,600 | D | ↗ |
| 2025-09-09 | Cunningham Ann Michelle | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 17,600 | 3.61 | 63.5K | 17,600 | D | ↗ |
| 2025-06-30 | Singh Shawn | Director / Officer | A-Award | A | Common Stock | 7,541 | 1.70 | 12.8K | 18,028 | D | ↗ |
| 2025-06-30 | Prince Joshua S. | Officer | A-Award | A | Common Stock | 4,882 | 1.70 | 8.3K | 10,863 | D | ↗ |
| 2025-06-30 | Anderson Cynthia Lynn | Officer | A-Award | A | Common Stock | 6,617 | 1.70 | 11.2K | 12,801 | D | ↗ |
| 2025-06-30 | Adler Reid G. | Officer | A-Award | A | Common Stock | 7,541 | 1.70 | 12.8K | 24,050 | D | ↗ |
| 2025-06-23 | Singh Shawn | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 300,000 | 1.96 | 588.0K | 300,000 | D | ↗ |
| 2025-06-23 | Prince Joshua S. | Officer | A-Award | A | Stock Option (Right to Buy) | 100,000 | 1.96 | 196.0K | 100,000 | D | ↗ |
| 2025-06-23 | Cote Elissa S. | Officer | A-Award | A | Stock Option (Right to Buy) | 150,000 | 1.96 | 294.0K | 150,000 | D | ↗ |
| 2025-06-23 | Anderson Cynthia Lynn | Officer | A-Award | A | Stock Option (Right to Buy) | 100,000 | 1.96 | 196.0K | 100,000 | D | ↗ |
| 2025-06-23 | Adler Reid G. | Officer | A-Award | A | Stock Option (Right to Buy) | 100,000 | 1.96 | 196.0K | 100,000 | D | ↗ |
| 2024-12-31 | Prince Joshua S. | Officer | A-Award | A | Common Stock | 3,310 | 2.51 | 8.3K | 5,981 | D | ↗ |
| 2024-12-31 | Anderson Cynthia Lynn | Officer | A-Award | A | Common Stock | 2,592 | 2.51 | 6.5K | 6,184 | D | ↗ |
| 2024-09-06 | SAXE JON S | Director | A-Award | A | Stock Option (Right to Buy) | 14,100 | 3.25 | 45.8K | 14,100 | — | ↗ |
| 2024-09-06 | Rotunno Mary L. | Director | A-Award | A | Stock Option (Right to Buy) | 14,100 | 3.25 | 45.8K | 14,100 | — | ↗ |
| 2024-09-06 | GIN JERRY B | Director | A-Award | A | Stock Option (Right to Buy) | 14,100 | 3.25 | 45.8K | 14,100 | — | ↗ |
| 2024-09-06 | FitzPatrick Margaret M | Director | A-Award | A | Stock Option (Right to Buy) | 14,100 | 3.25 | 45.8K | 14,100 | — | ↗ |
| 2024-09-06 | Curley Joanne | Director | A-Award | A | Stock Option (Right to Buy) | 14,100 | 3.25 | 45.8K | 14,100 | — | ↗ |
| 2024-09-06 | Cunningham Ann Michelle | Director | A-Award | A | Stock Option (Right to Buy) | 14,100 | 3.25 | 45.8K | 14,100 | — | ↗ |
| 2024-06-28 | Singh Shawn | Director / Officer | A-Award | A | Common Stock | 4,854 | 2.96 | 14.4K | 10,487 | — | ↗ |
| 2024-06-28 | Prince Joshua S. | Officer | A-Award | A | Common Stock | 2,671 | 2.96 | 7.9K | 2,671 | — | ↗ |
| 2024-06-28 | Anderson Cynthia Lynn | Officer | A-Award | A | Common Stock | 3,592 | 2.96 | 10.6K | 3,592 | — | ↗ |
| 2024-06-28 | Adler Reid G. | Officer | A-Award | A | Common Stock | 4,854 | 2.96 | 14.4K | 16,509 | — | ↗ |
| 2024-06-24 | Singh Shawn | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 500,000 | 3.23 | 1.62M | 500,000 | — | ↗ |
| 2024-06-24 | Prince Joshua S. | Officer | A-Award | A | Stock Option (Right to Buy) | 150,000 | 3.23 | 484.5K | 150,000 | — | ↗ |
| 2024-06-24 | Anderson Cynthia Lynn | Officer | A-Award | A | Stock Option (Right to Buy) | 150,000 | 3.23 | 484.5K | 150,000 | — | ↗ |
| 2024-06-24 | Adler Reid G. | Officer | A-Award | A | Stock Option (Right to Buy) | 170,000 | 3.23 | 549.1K | 170,000 | — | ↗ |
| 2024-03-04 | SAXE JON S | Director | A-Award | A | Stock Option (Right to Buy) | 12,500 | 4.85 | 60.6K | 12,500 | — | ↗ |
| 2024-03-04 | Rotunno Mary L. | Director | A-Award | A | Stock Option (Right to Buy) | 12,500 | 4.85 | 60.6K | 12,500 | — | ↗ |
| 2024-03-04 | GIN JERRY B | Director | A-Award | A | Stock Option (Right to Buy) | 12,500 | 4.85 | 60.6K | 12,500 | — | ↗ |
| 2024-03-04 | FitzPatrick Margaret M | Director | A-Award | A | Stock Option (Right to Buy) | 12,500 | 4.85 | 60.6K | 12,500 | — | ↗ |
| 2024-03-04 | Curley Joanne | Director | A-Award | A | Stock Option (Right to Buy) | 12,500 | 4.85 | 60.6K | 12,500 | — | ↗ |
| 2024-03-04 | Cunningham Ann Michelle | Director | A-Award | A | Stock Option (Right to Buy) | 12,500 | 4.85 | 60.6K | 12,500 | — | ↗ |
| 2023-12-29 | Singh Shawn | Director / Officer | A-Award | A | Common Stock | 167 | 1.72 | 286.74 | 5,633 | — | ↗ |
| 2023-12-29 | Adler Reid G. | Officer | A-Award | A | Common Stock | 167 | 1.72 | 286.74 | 11,655 | — | ↗ |
| 2023-10-24 | Prince Joshua S. | Officer | — | D | Stock Options (Right to buy) | 5,001 | 4.44 | 22.2K | 0 | — | ↗ |
| 2023-10-04 | COMMODORE CAPITAL LP | 10% Owner | A-Award | A | Tranche 2 Warrants (Right to Buy) | 1,690,014 | 8.88 | 15.00M | 1,690,014 | — | ↗ |
| 2023-08-21 | Anderson Cynthia Lynn | Officer | A-Award | A | Stock Option (right to buy) | 8,333 | 5.34 | 44.5K | 8,333 | — | ↗ |
| 2023-08-07 | COMMODORE CAPITAL LP | 10% Owner | P-Purchase | A | Common Stock | 775,756 | 23.15 | 17.96M | 1,575,000 | — | ↗ |
| 2023-06-30 | Singh Shawn | Director / Officer | A-Award | A | Common Stock | 167 | 1.59 | 265.45 | 5,466 | — | ↗ |
| 2023-06-30 | DOTSON JERROLD DUANE | Officer | A-Award | A | Common Stock | 167 | 1.59 | 265.45 | 3,671 | — | ↗ |
| 2023-06-30 | Adler Reid G. | Officer | A-Award | A | Common Stock | 167 | 1.59 | 265.45 | 11,488 | — | ↗ |
| 2022-12-30 | Singh Shawn | Director / Officer | A-Award | A | Common Stock | 5,000 | 0.09 | 438.00 | 158,998 | — | ↗ |
| 2022-12-30 | DOTSON JERROLD DUANE | Director | A-Award | A | Common Stock | 5,000 | 0.09 | 438.00 | 105,111 | — | ↗ |
| 2022-08-18 | GIN JERRY B | Director | P-Purchase | A | Common Stock | 100,000 | 0.18 | 17.9K | 100,000 | — | ↗ |
| 2022-08-17 | Singh Shawn | Director / Officer | P-Purchase | A | Common Stock | 600,000 | 0.17 | 103.2K | 626,234 | — | ↗ |
| 2022-08-17 | Adler Reid G. | Director / Officer | P-Purchase | A | Common Stock | 300,000 | 0.17 | 50.9K | 334,629 | — | ↗ |
| 2022-07-12 | Venrock Healthcare Capital Partners II, L.P. | 10% Owner | S-Sale | D | Common Stock | 60,000 | 0.89 | 53.4K | 20,637,286 | — | ↗ |
| 2022-07-12 | Shah Nimish P | Director | S-Sale | D | Common Stock | 60,000 | 0.89 | 53.4K | 20,637,286 | — | ↗ |
| 2022-06-30 | Smith Mark Alan | Director / Officer | A-Award | A | Common Stock | 5,000 | 0.75 | 3.7K | 19,915 | — | ↗ |
| 2022-06-30 | Singh Shawn | Director / Officer | A-Award | A | Common Stock | 5,000 | 0.75 | 3.7K | 153,998 | — | ↗ |
| 2022-06-30 | DOTSON JERROLD DUANE | Director | A-Award | A | Common Stock | 5,000 | 0.75 | 3.7K | 100,111 | — | ↗ |
| 2022-05-12 | Singh Shawn | Director / Officer | M-Exempt | A | Common Stock | 100,000 | 1.00 | 100.0K | 148,998 | — | ↗ |
| 2022-05-02 | Adler Reid G. | Officer | — | D | Stock Option (Right to Buy) | 2,500 | 8.00 | 20.0K | 0 | — | ↗ |
| 2022-04-06 | Venrock Healthcare Capital Partners II, L.P. | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 20,697,286 | — | ↗ |
| 2022-03-01 | Smith Mark Alan | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 150,000 | 0.00 | — | 150,000 | — | ↗ |
| 2022-03-01 | Singh Shawn | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 300,000 | 1.37 | 411.0K | 300,000 | — | ↗ |
| 2022-03-01 | SAXE JON S | Director | A-Award | A | Stock Option (Right to Buy) | 100,000 | 0.00 | — | 100,000 | — | ↗ |
| 2022-03-01 | Rotunno Mary L. | Director | A-Award | A | Stock Option (Right to Buy) | 100,000 | 1.37 | 137.0K | 100,000 | — | ↗ |
| 2022-03-01 | GIN JERRY B | Director | A-Award | A | Stock Option (Right to Buy) | 100,000 | 1.37 | 137.0K | 100,000 | — | ↗ |
| 2022-03-01 | FitzPatrick Margaret M | Director | A-Award | A | Stock Option (Right to Buy) | 100,000 | 1.37 | 137.0K | 100,000 | — | ↗ |
| 2022-03-01 | DOTSON JERROLD DUANE | Officer | A-Award | A | Stock Option (Right to Buy) | 150,000 | 1.37 | 205.5K | 150,000 | — | ↗ |
| 2022-03-01 | Curley Joanne | Director | A-Award | A | Stock Option (Right to Buy) | 100,000 | 1.37 | 137.0K | 100,000 | — | ↗ |
| 2022-03-01 | Cunningham Ann Michelle | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 150,000 | 0.00 | — | 150,000 | — | ↗ |
| 2022-01-11 | DOTSON JERROLD DUANE | Officer | M-Exempt | A | Common Stock | 18,750 | 1.00 | 18.8K | 94,571 | — | ↗ |
| 2021-12-31 | Smith Mark Alan | Officer | A-Award | A | Common Stock | 2,655 | 1.66 | 4.4K | 14,915 | — | ↗ |
| 2021-12-31 | Singh Shawn | Director / Officer | A-Award | A | Common Stock | 3,623 | 1.66 | 6.0K | 48,998 | — | ↗ |
| 2021-12-31 | SNODGRASS H. RALPH | Officer | A-Award | A | Common Stock | 3,623 | 1.66 | 6.0K | 64,958 | — | ↗ |
| 2021-12-31 | DOTSON JERROLD DUANE | Officer | A-Award | A | Common Stock | 3,575 | 1.66 | 5.9K | 75,821 | — | ↗ |
| 2021-09-07 | DOTSON JERROLD DUANE | Officer | S-Sale | D | Common Stock | 30,000 | 3.13 | 93.8K | 72,786 | — | ↗ |
| 2021-09-02 | SNODGRASS H. RALPH | Officer | G-Gift | A | Common Stock | 1,111 | 0.00 | — | 61,335 | — | ↗ |
| 2021-08-23 | SNODGRASS H. RALPH | Officer | G-Gift | D | Common Stock | 740 | 0.00 | — | 33,901 | — | ↗ |
| 2021-08-17 | SNODGRASS H. RALPH | Officer | P-Purchase | A | Common Stock | 3,750 | 2.73 | 10.2K | 34,641 | — | ↗ |
| 2021-07-21 | FitzPatrick Margaret M | Director | A-Award | A | Stock Option (Right to Buy) | 75,000 | 2.93 | 219.8K | 75,000 | — | ↗ |
| 2021-07-06 | Rotunno Mary L. | Director | A-Award | A | Stock Option (Right to Buy) | 75,000 | 3.33 | 249.8K | 75,000 | — | ↗ |
| 2021-06-30 | Smith Mark Alan | Officer | A-Award | A | Common Stock | 2,260 | 1.95 | 4.4K | 12,260 | — | ↗ |
| 2021-06-30 | Singh Shawn | Director / Officer | A-Award | A | Common Stock | 5,000 | 1.95 | 9.7K | 45,375 | — | ↗ |
| 2021-06-30 | SNODGRASS H. RALPH | Officer | A-Award | A | Common Stock | 3,391 | 1.95 | 6.6K | 91,115 | — | ↗ |
| 2021-06-30 | DOTSON JERROLD DUANE | Officer | M-Exempt | D | Stock Option (Right to Buy) | 1,000 | 1.50 | 1.5K | 0 | — | ↗ |
| 2021-05-01 | Cunningham Ann Michelle | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 300,000 | 2.53 | 759.0K | 300,000 | — | ↗ |
| 2021-04-23 | Singh Shawn | Director / Officer | M-Exempt | A | Common Stock | 5,000 | 1.50 | 7.5K | 40,375 | — | ↗ |
| 2021-04-23 | Curley Joanne | Director | A-Award | A | Stock Option (Right to Buy) | 75,000 | 2.04 | 153.0K | 75,000 | — | ↗ |
| 2021-03-19 | Underdown Brian J. | Director | M-Exempt | A | Common Stock | 2,500 | 1.50 | 3.8K | 2,500 | — | ↗ |
| 2021-03-19 | SAXE JON S | Director | M-Exempt | A | Common Stock | 2,500 | 1.50 | 3.8K | 5,751 | — | ↗ |
| 2021-02-01 | Ginski Mark J | Officer | A-Award | A | Stock Options (Right to Buy) | 200,000 | 2.14 | 428.0K | 200,000 | — | ↗ |
| 2020-12-31 | Smith Mark Alan | Officer | A-Award | A | Common Stock | 5,000 | 0.45 | 2.3K | 10,000 | — | ↗ |
| 2020-12-31 | Singh Shawn | Director / Officer | A-Award | A | Common Stock | 5,000 | 0.45 | 2.3K | 35,375 | — | ↗ |
| 2020-12-31 | SNODGRASS H. RALPH | Director / Officer | A-Award | A | Common Stock | 5,000 | 0.45 | 2.3K | 87,724 | — | ↗ |
| 2020-12-31 | DOTSON JERROLD DUANE | Officer | A-Award | A | Common Stock | 5,000 | 0.45 | 2.3K | 10,000 | — | ↗ |
| 2020-12-30 | Underdown Brian J. | Director | A-Award | A | Stock Option (Right to Buy) | 75,000 | 1.77 | 132.8K | 75,000 | — | ↗ |
| 2020-12-30 | Smith Mark Alan | Officer | A-Award | A | Stock Option (Right to Buy) | 150,000 | 1.77 | 265.5K | 150,000 | — | ↗ |
| 2020-12-30 | Singh Shawn | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 300,000 | 1.77 | 531.0K | 300,000 | — | ↗ |
| 2020-12-30 | SNODGRASS H. RALPH | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 150,000 | 1.77 | 265.5K | 150,000 | — | ↗ |
| 2020-12-30 | SAXE JON S | Director | A-Award | A | Stock Option (Right to Buy) | 75,000 | 1.77 | 132.8K | 75,000 | — | ↗ |
| 2020-12-30 | MCPARTLAND MARK A. | Officer | A-Award | A | Stock Option (Right to Buy) | 150,000 | 1.77 | 265.5K | 150,000 | — | ↗ |
| 2020-12-30 | GIN JERRY B | Director | A-Award | A | Stock Option (Right to Buy) | 75,000 | 1.77 | 132.8K | 75,000 | — | ↗ |
| 2020-12-30 | DOTSON JERROLD DUANE | Officer | A-Award | A | Stock Option (Right to Buy) | 150,000 | 1.77 | 265.5K | 150,000 | — | ↗ |
| 2020-12-30 | Cunningham Ann Michelle | Director | A-Award | A | Stock Option (Right to Buy) | 75,000 | 1.77 | 132.8K | 75,000 | — | ↗ |
| 2020-08-21 | SAXE JON S | Director | P-Purchase | A | Common Stock | 30,000 | 0.69 | 20.7K | 50,000 | — | ↗ |
| 2020-06-30 | Smith Mark Alan | Officer | A-Award | A | Common Stock | 5,000 | 0.45 | 2.2K | 5,000 | — | ↗ |
| 2020-06-30 | Singh Shawn | Director / Officer | A-Award | A | Common Stock | 5,000 | 0.45 | 2.2K | 30,375 | — | ↗ |
| 2020-06-30 | SNODGRASS H. RALPH | Director / Officer | A-Award | A | Common Stock | 5,000 | 0.45 | 2.2K | 67,724 | — | ↗ |
| 2020-06-30 | DOTSON JERROLD DUANE | Officer | A-Award | A | Common Stock | 5,000 | 0.45 | 2.2K | 5,000 | — | ↗ |
| 2020-04-23 | Underdown Brian J. | Director | A-Award | A | Stock Option (Right to Buy) | 75,000 | 0.40 | 29.9K | 75,000 | — | ↗ |
| 2020-04-23 | Smith Mark Alan | Officer | A-Award | A | Stock Option (Right to Buy) | 150,000 | 0.40 | 59.7K | 150,000 | — | ↗ |
| 2020-04-23 | Singh Shawn | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 300,000 | 0.40 | 119.4K | 300,000 | — | ↗ |
| 2020-04-23 | SNODGRASS H. RALPH | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 150,000 | 0.40 | 59.7K | 150,000 | — | ↗ |
| 2020-04-23 | SAXE JON S | Director | A-Award | A | Stock Option (Right to Buy) | 75,000 | 0.40 | 29.9K | 75,000 | — | ↗ |
| 2020-04-23 | MCPARTLAND MARK A. | Officer | A-Award | A | Stock Option (Right to Buy) | 150,000 | 0.40 | 59.7K | 150,000 | — | ↗ |
| 2020-04-23 | GIN JERRY B | Director | A-Award | A | Stock Option (Right to Buy) | 75,000 | 0.40 | 29.9K | 75,000 | — | ↗ |
| 2020-04-23 | DOTSON JERROLD DUANE | Officer | A-Award | A | Stock Option (Right to Buy) | 150,000 | 0.40 | 59.7K | 150,000 | — | ↗ |
| 2020-04-23 | Cunningham Ann Michelle | Director | A-Award | A | Stock Option (Right to Buy) | 75,000 | 0.40 | 29.9K | 75,000 | — | ↗ |
| 2019-11-20 | SNODGRASS H. RALPH | Director / Officer | P-Purchase | A | Common Stock | 15,000 | 0.34 | 5.1K | 15,000 | — | ↗ |
| 2019-10-21 | Underdown Brian J. | Director | A-Award | A | Stock Option (Right to Buy) | 75,000 | 1.41 | 105.8K | 75,000 | — | ↗ |
| 2019-10-21 | Smith Mark Alan | Officer | A-Award | A | Stock Option (Right to Buy) | 100,000 | 1.41 | 141.0K | 100,000 | — | ↗ |
| 2019-10-21 | Singh Shawn | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 300,000 | 1.41 | 423.0K | 300,000 | — | ↗ |
| 2019-10-21 | SNODGRASS H. RALPH | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 175,000 | 1.41 | 246.8K | 175,000 | — | ↗ |
| 2019-10-21 | SAXE JON S | Director | A-Award | A | Stock Option (Right to Buy) | 75,000 | 1.41 | 105.8K | 75,000 | — | ↗ |
| 2019-10-21 | MCPARTLAND MARK A. | Officer | A-Award | A | Stock Option (Right to Buy) | 100,000 | 1.41 | 141.0K | 100,000 | — | ↗ |
| 2019-10-21 | GIN JERRY B | Director | A-Award | A | Stock Option (Right to Buy) | 75,000 | 1.41 | 105.8K | 75,000 | — | ↗ |
| 2019-10-21 | DOTSON JERROLD DUANE | Officer | A-Award | A | Stock Option (Right to Buy) | 150,000 | 1.41 | 211.5K | 150,000 | — | ↗ |
| 2019-10-21 | Cunningham Ann Michelle | Director | A-Award | A | Stock Option (Right to Buy) | 75,000 | 1.41 | 105.8K | 75,000 | — | ↗ |
| 2019-05-28 | Singh Shawn | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 170,000 | 1.00 | 170.0K | 170,000 | — | ↗ |
| 2019-05-23 | Underdown Brian J. | Director | A-Award | A | Stock Option (Right to Buy) | 50,000 | 1.00 | 50.0K | 50,000 | — | ↗ |
| 2019-05-23 | Smith Mark Alan | Officer | A-Award | A | Stock Option (Right to Buy) | 150,000 | 1.00 | 150.0K | 150,000 | — | ↗ |
| 2019-05-23 | Singh Shawn | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 80,000 | 1.00 | 80.0K | 80,000 | — | ↗ |
| 2019-05-23 | SNODGRASS H. RALPH | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 150,000 | 1.00 | 150.0K | 150,000 | — | ↗ |
| 2019-05-23 | SAXE JON S | Director | A-Award | A | Stock Option (Right to Buy) | 50,000 | 1.00 | 50.0K | 50,000 | — | ↗ |
| 2019-05-23 | MCPARTLAND MARK A. | Officer | A-Award | A | Stock Option (Right to Buy) | 150,000 | 1.00 | 150.0K | 150,000 | — | ↗ |
| 2019-05-23 | GIN JERRY B | Director | A-Award | A | Stock Option (Right to Buy) | 50,000 | 1.00 | 50.0K | 50,000 | — | ↗ |
| 2019-05-23 | DOTSON JERROLD DUANE | Officer | A-Award | A | Stock Option (Right to Buy) | 150,000 | 1.00 | 150.0K | 150,000 | — | ↗ |
| 2019-05-23 | Cunningham Ann Michelle | Director | A-Award | A | Stock Option (Right to Buy) | 50,000 | 1.00 | 50.0K | 50,000 | — | ↗ |
| 2019-03-14 | SAXE JON S | Director | P-Purchase | A | Common Stock | 7,920 | 1.27 | 10.1K | 20,000 | — | ↗ |
| 2019-03-13 | SNODGRASS H. RALPH | Director / Officer | M-Exempt | A | Common Stock | 2,500 | 1.50 | 3.8K | 62,724 | — | ↗ |
| 2019-03-13 | SAXE JON S | Director | P-Purchase | A | Common Stock | 12,080 | 1.26 | 15.2K | 12,080 | — | ↗ |
| 2019-01-29 | SAXE JON S | Director | M-Exempt | A | Common Stock | 375 | 1.50 | 562.50 | 2,251 | — | ↗ |
| 2019-01-14 | Singh Shawn | Director / Officer | M-Exempt | A | Common Stock | 1,125 | 1.50 | 1.7K | 22,375 | — | ↗ |
| 2019-01-10 | Cunningham Ann Michelle | Director | A-Award | A | Stock Option (Right to Buy) | 25,000 | 1.74 | 43.5K | 25,000 | — | ↗ |
| 2018-08-29 | Underdown Brian J. | Director | A-Award | A | Stock Option (Right to Buy) | 35,000 | 1.50 | 52.5K | 35,000 | — | ↗ |
| 2018-08-29 | Smith Mark Alan | Officer | D-Return | D | Stock Option (Right to Buy) | 80,000 | 3.80 | 304.0K | 0 | — | ↗ |
| 2018-08-29 | Singh Shawn | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 1,125 | 1.50 | 1.7K | 1,125 | — | ↗ |
| 2018-08-29 | SNODGRASS H. RALPH | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 12,500 | 1.50 | 18.8K | 12,500 | — | ↗ |
| 2018-08-29 | SAXE JON S | Director | A-Award | A | Stock Option (Right to Buy) | 1,000 | 1.50 | 1.5K | 1,000 | — | ↗ |
| 2018-08-29 | MCPARTLAND MARK A. | Officer | A-Award | A | Stock Option (Right to Buy) | 125,000 | 1.50 | 187.5K | 125,000 | — | ↗ |
| 2018-08-29 | GIN JERRY B | Director | A-Award | A | Stock Option (Right to Buy) | 25,000 | 1.50 | 37.5K | 25,000 | — | ↗ |
| 2018-08-29 | DOTSON JERROLD DUANE | Officer | A-Award | A | Stock Option (Right to Buy) | 4,323 | 1.50 | 6.5K | 4,323 | — | ↗ |
| 2018-08-05 | Underdown Brian J. | Director | A-Award | A | Stock Option (Right to Buy) | 75,000 | 1.27 | 95.3K | 75,000 | — | ↗ |
| 2018-08-05 | Smith Mark Alan | Officer | A-Award | A | Stock Option (Right to Buy) | 100,000 | 1.27 | 127.0K | 100,000 | — | ↗ |
| 2018-08-05 | SNODGRASS H. RALPH | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 125,000 | 1.27 | 158.8K | 125,000 | — | ↗ |
| 2018-08-05 | SAXE JON S | Director | A-Award | A | Stock Option (Right to Buy) | 75,000 | 1.27 | 95.3K | 75,000 | — | ↗ |
| 2018-08-05 | MCPARTLAND MARK A. | Officer | A-Award | A | Stock Option (Right to Buy) | 150,000 | 1.27 | 190.5K | 150,000 | — | ↗ |
| 2018-08-05 | GIN JERRY B | Director | A-Award | A | Stock Option (Right to Buy) | 75,000 | 1.27 | 95.3K | 75,000 | — | ↗ |
| 2018-08-05 | DOTSON JERROLD DUANE | Officer | A-Award | A | Stock Option (Right to Buy) | 100,000 | 1.27 | 127.0K | 100,000 | — | ↗ |
| 2018-02-02 | Underdown Brian J. | Director | A-Award | A | Stock Option (Right to Buy) | 100,000 | 1.16 | 116.0K | 100,000 | — | ↗ |
| 2018-02-02 | Smith Mark Alan | Officer | A-Award | A | Stock Option (Right to Buy) | 200,000 | 1.16 | 232.0K | 200,000 | — | ↗ |
| 2018-02-02 | Singh Shawn | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 300,000 | 1.16 | 348.0K | 300,000 | — | ↗ |
| 2018-02-02 | SNODGRASS H. RALPH | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 175,000 | 1.16 | 203.0K | 175,000 | — | ↗ |
| 2018-02-02 | SAXE JON S | Director | A-Award | A | Stock Option (Right to Buy) | 100,000 | 1.16 | 116.0K | 100,000 | — | ↗ |
| 2018-02-02 | MCPARTLAND MARK A. | Officer | A-Award | A | Stock Option (Right to Buy) | 150,000 | 1.16 | 174.0K | 150,000 | — | ↗ |
| 2018-02-02 | GIN JERRY B | Director | A-Award | A | Stock Option (Right to Buy) | 100,000 | 1.16 | 116.0K | 100,000 | — | ↗ |
| 2018-02-02 | DOTSON JERROLD DUANE | Officer | A-Award | A | Stock Option (Right to Buy) | 200,000 | 1.16 | 232.0K | 200,000 | — | ↗ |
| 2017-09-19 | Underdown Brian J. | Director | A-Award | A | Stock Option (Right to Buy) | 50,000 | 1.56 | 78.0K | 50,000 | — | ↗ |
| 2017-09-19 | Smith Mark Alan | Officer | A-Award | A | Stock Option (Right to Buy) | 100,000 | 1.56 | 156.0K | 100,000 | — | ↗ |
| 2017-09-19 | Singh Shawn | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 125,000 | 1.56 | 195.0K | 125,000 | — | ↗ |
| 2017-09-19 | SNODGRASS H. RALPH | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 100,000 | 1.56 | 156.0K | 100,000 | — | ↗ |
| 2017-09-19 | SAXE JON S | Director | A-Award | A | Stock Option (Right to Buy) | 50,000 | 1.56 | 78.0K | 50,000 | — | ↗ |
| 2017-09-19 | MCPARTLAND MARK A. | Officer | — | D | Stock Option (Right to Buy) | 125,000 | 4.27 | 533.8K | 0 | — | ↗ |
| 2017-09-19 | GIN JERRY B | Director | A-Award | A | Stock Option (Right to Buy) | 50,000 | 1.56 | 78.0K | 50,000 | — | ↗ |
| 2017-09-19 | DOTSON JERROLD DUANE | Officer | A-Award | A | Stock Option (Right to Buy) | 100,000 | 1.56 | 156.0K | 100,000 | — | ↗ |
| 2017-09-15 | GIN JERRY B | Director | D-Return | D | Warrant | 25,000 | 4.00 | 100.0K | 0 | — | ↗ |
| 2017-05-31 | GIN JERRY B | Director | P-Purchase | A | Warrant | 25,000 | 4.00 | 100.0K | 50,000 | — | ↗ |
| 2017-04-26 | Underdown Brian J. | Director | A-Award | A | Stock Option (Right to Buy) | 35,000 | 1.96 | 68.6K | 35,000 | — | ↗ |
| 2017-04-26 | Smith Mark Alan | Officer | A-Award | A | Stock Option (Right to Buy) | 125,000 | 1.96 | 245.0K | 125,000 | — | ↗ |
| 2017-04-26 | Singh Shawn | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 175,000 | 1.96 | 343.0K | 175,000 | — | ↗ |
| 2017-04-26 | SNODGRASS H. RALPH | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 125,000 | 1.96 | 245.0K | 125,000 | — | ↗ |
| 2017-04-26 | SAXE JON S | Director | A-Award | A | Stock Option (Right to Buy) | 35,000 | 1.96 | 68.6K | 35,000 | — | ↗ |
| 2017-04-26 | GIN JERRY B | Director | A-Award | A | Stock Option (Right to Buy) | 35,000 | 1.96 | 68.6K | 35,000 | — | ↗ |
| 2017-04-26 | DOTSON JERROLD DUANE | Officer | A-Award | A | Stock Option (Right to Buy) | 100,000 | 1.96 | 196.0K | 100,000 | — | ↗ |
| 2016-11-09 | Underdown Brian J. | Director | A-Award | A | Stock Option (Right to Buy) | 25,000 | 3.80 | 95.0K | 25,000 | — | ↗ |
| 2016-11-09 | Smith Mark Alan | Officer | A-Award | A | Stock Option (Right to Buy) | 80,000 | 3.80 | 304.0K | 80,000 | — | ↗ |
| 2016-11-09 | Singh Shawn | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 100,000 | 3.80 | 380.0K | 100,000 | — | ↗ |
| 2016-11-09 | SNODGRASS H. RALPH | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 80,000 | 3.80 | 304.0K | 80,000 | — | ↗ |
| 2016-11-09 | SAXE JON S | Director | A-Award | A | Stock Option (Right to Buy) | 25,000 | 3.80 | 95.0K | 25,000 | — | ↗ |
| 2016-11-09 | GIN JERRY B | Director | A-Award | A | Stock Option (Right to Buy) | 25,000 | 3.80 | 95.0K | 25,000 | — | ↗ |
| 2016-11-09 | DOTSON JERROLD DUANE | Officer | A-Award | A | Stock Option (Right to Buy) | 50,000 | 3.80 | 190.0K | 50,000 | — | ↗ |
| 2016-06-19 | Underdown Brian J. | Director | A-Award | A | Stock Option (Right to Buy) | 25,000 | 3.49 | 87.3K | 25,000 | — | ↗ |
| 2016-06-19 | Smith Mark Alan | Officer | A-Award | A | Stock Option (Right to Buy) | 180,000 | 3.49 | 628.2K | 180,000 | — | ↗ |
| 2016-06-19 | Singh Shawn | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 200,000 | 3.49 | 698.0K | 200,000 | — | ↗ |
Executive team
Top executives
Shares Outstanding
32.77M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Shawn K. Singh, J.D. President, Chief Executive Officer and Director | 650.0K | 276.3K | — | 1.55M | — | — | 2.48M | 62.62% | ↗ |
| 2 | 2025 | Reid G. Adler, J.D. Chief Legal Officer | 450.0K | 198.5K | — | 527.4K | — | — | 1.18M | 44.85% | ↗ |
| 3 | 2025 | Cynthia L. Anderson, CPA Chief Financial Officer and Treasurer | 443.8K | 198.5K | — | 465.3K | — | — | 1.11M | 42.01% | ↗ |
| 4 | 2025 | Joshua S. Prince, MBA Chief Operating Officer | 410.0K | 183.0K | — | 465.2K | — | — | 1.06M | 43.96% | ↗ |
| 5 | 2024 | Shawn K. Singh, J.D. Chief Executive Officer | 622.9K | 325.0K | — | — | — | — | 947.9K | 0.00% | ↗ |
| 6 | 2024 | Shawn K. Singh, J.D. President, Chief Executive Officer and Director | 622.9K | 325.0K | — | — | — | — | 947.9K | 0.00% | ↗ |
| 7 | 2024 | Reid G. Adler, J.D. Chief Legal Officer | 450.0K | 225.0K | — | — | — | — | 675.0K | 0.00% | ↗ |
| 8 | 2024 | Reid G. Adler, J.D. Chief Corporate Development Officer and General Counsel | 450.0K | 225.0K | — | — | — | — | 675.0K | 0.00% | ↗ |
| 9 | 2024 | Joshua S. Prince, MBA Chief Operating Officer | 368.4K | 200.0K | — | — | — | — | 568.4K | 0.00% | ↗ |
| 10 | 2024 | Cynthia L. Anderson, CPA Chief Financial Officer and Treasurer | 261.2K | 130.0K | — | 43.0K | — | — | 434.2K | 9.90% | ↗ |
| 11 | 2024 | Cynthia L. Anderson, CPA Chief Financial Officer | 261.2K | 130.0K | — | 43.0K | — | — | 434.2K | 9.90% | ↗ |
| 12 | 2023 | Shawn K. Singh, J.D. Chief Executive Officer | 600.0K | — | — | — | — | — | 600.0K | 0.00% | ↗ |
| 13 | 2023 | Reid G. Adler, J.D. Chief Corporate Development Officer and General Counsel | 371.9K | — | — | 180.6K | — | — | 552.4K | 32.69% | ↗ |
| 14 | 2023 | Jerrold D. Dotson, CPA Chief Financial Officer | 434.4K | — | — | — | — | — | 434.4K | 0.00% | ↗ |
| 15 | 2022 | Ann M. Cunningham Chief Commercial Officer | 395.8K | 140.0K | — | 668.8K | — | — | 1.20M | 55.52% | ↗ |
| 16 | 2022 | Shawn K. Singh, J.D. Chief Executive Officer | 562.5K | 350.0K | — | 270.0K | — | — | 1.18M | 22.83% | ↗ |
| 17 | 2022 | Shawn K. Singh Chief Executive Officer | 562.5K | 350.0K | — | 270.0K | — | — | 1.18M | 22.83% | ↗ |
| 18 | 2022 | Mark A. Smith, M.D., Ph.D. Chief Medical Officer | 448.8K | 210.0K | — | 134.6K | — | — | 793.4K | 16.97% | ↗ |
| 19 | 2022 | Jerrold D. Dotson, CPA Chief Financial Officer | 402.5K | 175.0K | — | 134.6K | — | — | 712.1K | 18.90% | ↗ |
| 20 | 2022 | Jerrold D. Dotson Vice President, Chief Financial Officer and Secretary | 402.5K | 175.0K | — | 134.6K | — | — | 712.1K | 18.90% | ↗ |
| 21 | 2021 | Shawn K. Singh, J.D. Chief Executive Officer | 511.0K | 333.7K | — | 439.6K | — | — | 1.28M | 34.23% | ↗ |
| 22 | 2021 | Shawn K. Singh Chief Executive Officer | 511.0K | 333.7K | — | 439.6K | — | — | 1.28M | 34.23% | ↗ |
| 23 | 2021 | Mark A. Smith, M.D., Ph.D. Chief Medical Officer | 422.6K | 125.1K | — | 219.4K | — | — | 767.1K | 28.61% | ↗ |
| 24 | 2021 | H. Ralph Snodgrass, Ph.D. President, Chief Scientific Officer | 422.6K | 125.1K | — | 219.4K | — | — | 767.1K | 28.60% | ↗ |
| 25 | 2021 | Jerrold D. Dotson Vice President, Chief Financial Officer and Secretary | 374.4K | 110.3K | — | 219.4K | — | — | 704.0K | 31.16% | ↗ |
| 26 | 2020 | Shawn K. Singh, J.D. Chief Executive Officer | 498.0K | — | — | 435.7K | — | — | 933.7K | 46.66% | ↗ |
| 27 | 2020 | H. Ralph Snodgrass, Ph.D. President, Chief Scientific Officer | 416.9K | — | — | 254.4K | — | — | 671.3K | 37.90% | ↗ |
| 28 | 2020 | Jerrold D. Dotson Vice President, Chief Financial Officer and Secretary | 367.5K | — | — | 229.6K | — | — | 597.1K | 38.45% | ↗ |
| 29 | 2020 | Mark A. Smith, M.D., Ph.D. Chief Medical Officer | 416.9K | — | — | 180.0K | — | — | 596.8K | 30.16% | ↗ |
| 30 | 2020 | Mark A. McPartland Vice President, Corporate Development | 300.0K | — | — | 180.0K | — | — | 480.0K | 37.50% | ↗ |
| 31 | 2019 | Shawn K. Singh, J.D. Chief Executive Officer | 466.4K | 110.3K | — | 374.4K | — | — | 951.1K | 39.37% | ↗ |
| 32 | 2019 | Shawn K. Singh Chief Executive Officer | 466.4K | 110.3K | — | 374.4K | — | — | 951.1K | 39.37% | ↗ |
| 33 | 2019 | H. Ralph Snodgrass, Ph.D. President. Chief Scientific Officer | 394.0K | 73.4K | — | 174.8K | — | — | 642.3K | 27.22% | ↗ |
| 34 | 2019 | H. Ralph Snodgrass, Ph.D. President, Chief Scientific Officer | 394.0K | 73.4K | — | 174.8K | — | — | 642.3K | 27.22% | ↗ |
| 35 | 2019 | Mark A. Smith, M.D., Ph.D. Chief Medical Officer | 394.0K | 73.4K | — | 154.9K | — | — | 622.4K | 24.89% | ↗ |
| 36 | 2019 | Jerrold D. Dotson Vice President, Chief Financial Officer and Secretary | 345.0K | 64.7K | — | 131.3K | — | — | 541.1K | 24.27% | ↗ |
| 37 | 2019 | Mark A. McPartland Vice President, Corporate Development | 268.8K | 50.9K | — | 187.0K | — | — | 506.6K | 36.91% | ↗ |
| 38 | 2018 | Shawn K. Singh Chief Executive Officer | 424.6K | 206.4K | — | 641.9K | — | — | 1.27M | 50.43% | ↗ |
| 39 | 2018 | Mark A. Smith, M.D., Ph.D. Chief Medical Officer | 376.2K | 146.3K | — | 458.5K | — | — | 981.0K | 46.74% | ↗ |
| 40 | 2018 | H. Ralph Snodgrass, Ph.D. President. Chief Scientific Officer | 376.2K | 128.0K | — | 437.0K | — | — | 941.2K | 46.43% | ↗ |
| 41 | 2018 | Jerrold D. Dotson Vice President, Chief Financial Officer and Secretary | 322.5K | 125.4K | — | 423.9K | — | — | 871.8K | 48.63% | ↗ |
| 42 | 2018 | Mark A. McPartland Vice President, Corporate Development | 240.8K | 83.1K | — | 324.0K | — | — | 647.9K | 50.00% | ↗ |
| 43 | 2017 | Shawn K. Singh Chief Executive Officer | 385.1K | 173.8K | — | 757.2K | — | — | 1.32M | 57.54% | ↗ |
| 44 | 2017 | H. Ralph Snodgrass, Ph.D. President, Chief Scientific Officer | 340.6K | 152.5K | — | 520.9K | — | — | 1.01M | 51.37% | ↗ |
| 45 | 2017 | H. Ralph Snodgrass, Ph.D. President. Chief Scientific Officer | 340.6K | 152.5K | — | 520.9K | — | — | 1.01M | 51.37% | ↗ |
| 46 | 2017 | Mark A. Smith, M.D., Ph.D. Chief Medical Officer | 275.7K | — | — | 654.2K | — | — | 930.0K | 70.35% | ↗ |
| 47 | 2017 | Jerrold D. Dotson Vice President, Chief Financial Officer, Secretary | 289.6K | 100.0K | — | 318.0K | — | — | 707.6K | 44.94% | ↗ |
| 48 | 2017 | Jerrold D. Dotson Vice President, Chief Financial Officer and Secretary | 289.6K | 100.0K | — | 318.0K | — | — | 707.6K | 44.94% | ↗ |
| 49 | 2016 | Shawn K. Singh Chief Executive Officer | 347.5K | — | — | 1.63M | — | — | 1.98M | 82.42% | ↗ |
| 50 | 2016 | H. Ralph Snodgrass, Ph.D President, Chief Scientific Officer | 305.0K | — | — | 985.0K | — | — | 1.29M | 76.36% | ↗ |
| 51 | 2016 | H. Ralph Snodgrass, Ph.D. President, Chief Scientific Officer | 305.0K | — | — | 985.0K | — | — | 1.29M | 76.36% | ↗ |
| 52 | 2016 | Jerrold D. Dotson Vice President, Chief Financial Officer, Secretary | 250.0K | — | — | 635.3K | — | — | 885.3K | 71.76% | ↗ |
| 53 | 2015 | Shawn K. Singh Chief Executive Officer | 347.5K | — | — | 688.1K | — | — | 1.04M | 66.44% | ↗ |
| 54 | 2015 | H. Ralph Snodgrass, Ph.D President, Chief Scientific Officer | 305.0K | — | — | 458.7K | — | — | 763.7K | 60.06% | ↗ |
| 55 | 2015 | Jerrold D. Dotson Vice President, Chief Financial Officer, Secretary | 250.0K | — | — | 229.4K | — | — | 479.4K | 47.85% | ↗ |
CEO compensation breakdown
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Shawn K. Singh | President, Chief Executive Officer & Director | 926.3K | male |
| Reid G. Adler | Chief Legal Officer | 648.5K | male |
| Joshua Prince | Chief Operating Officer | 593.0K | male |
| Mark Adrian McPartland | Senior Vice President of Investor Relations | 300.0K | male |
| Nick Tressler | CFO, Principal Financial & Accounting Officer and Treasurer | — | male |
| Allen Easley Cato | Senior Vice President of Integrated Drug Development | — | — |
| Trisha Fitzmaurice | Senior Vice President of Human Resources | — | female |
| Elissa Cote | Chief Corporate Development Officer | — | female |
| Mark J. Ginski | Senior Vice President and Head of Chemistry, Manufacturing & Controls | — | — |
| Michelle Peters Wellington | Vice President of Communications | — | female |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for VTGN
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
